CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
Miami, Florida, United States and 12 other locations
Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...
Phase 3
Miami, Florida, United States and 5 other locations
to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients refractory to prior treatment of metastatic pancreatic...
Phase 1, Phase 2
Boca Raton, Florida, United States and 5 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Miami, Florida, United States and 135 other locations
A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...
Phase 1
Miami Beach, Florida, United States and 22 other locations
and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...
Phase 1
Plantation, Florida, United States of America and 17 other locations
evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1 antibody-based SoC therapy in adult patients with solid tumors...
Phase 2
Miami Beach, Florida, United States and 21 other locations
The study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma whic...
Phase 3
Miami, Florida, United States and 40 other locations
followed by stereotactic ablative body radiation therapy (SABR) and tumor treating fields (TTF) will slow tumor growth in people wi ...
Miami, Florida, United States
intracellular domain via a transmembrane domain. Thus, the switch is designed to produce a costimulatory signal upon engagement with PD-L1 on cancer...
Phase 1, Phase 2
Miami, Florida, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal